A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.” Apr 2, 2025Authors: Aragona C, Russo M, Myers SH, Espinola MSB, Bilotta G, Unfer V.
